Michael Obermeier

3.7k total citations
65 papers, 2.5k citations indexed

About

Michael Obermeier is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Michael Obermeier has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 18 papers in Pharmacology and 15 papers in Clinical Psychology. Recurrent topics in Michael Obermeier's work include Schizophrenia research and treatment (30 papers), Treatment of Major Depression (18 papers) and Bipolar Disorder and Treatment (15 papers). Michael Obermeier is often cited by papers focused on Schizophrenia research and treatment (30 papers), Treatment of Major Depression (18 papers) and Bipolar Disorder and Treatment (15 papers). Michael Obermeier collaborates with scholars based in Germany, United States and United Kingdom. Michael Obermeier's co-authors include Michael Riedel, Richard Musil, Florian Seemüller, Rebecca Schennach-Wolff, Wolfgang Gäebel, Isabella Heuser, Hans‐Jürgen Möller, Norbert Müller, Daniela Krause and Gerd Laux and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Journal of Affective Disorders.

In The Last Decade

Michael Obermeier

64 papers receiving 2.5k citations

Peers

Countries citing papers authored by Michael Obermeier

Since Specialization

Citations

This map shows the geographic impact of Michael Obermeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Obermeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Obermeier more than expected).

Fields of papers citing papers by Michael Obermeier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Obermeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Obermeier. The network helps show where Michael Obermeier may publish in the future.

Co-authorship network of co-authors of Michael Obermeier

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Obermeier. A scholar is included among the top collaborators of Michael Obermeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Obermeier. Michael Obermeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen 2024 ·International Journal of Clinical Pharmacology and Therapeutics ·Burkhard Otremba, Ferdinand Haslbauer, Marcel Reiser, Rudolf Weide, Michael Obermeier, (unknown)	1
2	A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients 2023 ·BMC Psychiatry ·Florian Seemüller, Rebecca Schennach, Richard Musil, Michael Obermeier, Mazda Adli, Michael Bauer, Peter Brieger, Gerd Laux, Wolfgang Gäebel, Peter Falkai, Michael Riedel, Hans‐Jürgen Möller	26
3	THU0165 PROSARA - A PROSPECTIVE, MULTICENTER, NON-INTERVENTIONAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF SARILUMAB FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN REGULAR CARE IN GERMANY 2020 ·Annals of the Rheumatic Diseases ·Eugen Feist, Peer Aries, (unknown), Harald Burkhardt, Inka Albrecht, (unknown), Michael Obermeier, (unknown), Martin Welcker, (unknown), (unknown), N.T. Baerlecken, H-P Tony	1
4	Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients 2016 ·BMC Psychiatry ·Florian Seemüller, Michael Obermeier, Rebecca Schennach, Michael Bauer, Mazda Adli, Peter Brieger, Gerd Laux, Michael Riedel, Peter Falkai, Hans‐Jürgen Möller	7
5	What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder? 2014 ·European Psychiatry ·Rebecca Schennach, Michael Riedel, Michael Obermeier, Florian Seemüller, Markus Jäger, Max Schmauß, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz Schmidt, Wolfgang Gäebel, Joachim Klosterkötter, Isabella Heuser, W. Maier, Matthias Lemke, E. Rüther, Stefan Klingberg, Markus Gastpar, H.‐J. Möller	19
6	Functional outcome and quality of life in Tourette's syndrome after deep brain stimulation of the posteroventrolateral globus pallidus internus: long-term follow-up 2013 ·The World Journal of Biological Psychiatry ·Sandra Dehning, Bianka Leitner, Rebecca Schennach, Norbert Müller, Kai Bötzel, Michael Obermeier, Jan‐Hinnerk Mehrkens	24
7	No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression 2012 ·European Archives of Psychiatry and Clinical Neuroscience ·Richard Musil, Peter Zill, Florian Seemüller, Brigitta Bondy, Michael Obermeier, Ilja Spellmann, Wolfram Bender, Mazda Adli, Isabella Heuser, Joachim Zeiler, Wolfgang Gäebel, Wolfgang Maier, Marcella Rietschel, Dan Rujescu, Rebecca Schennach, Hans‐Jürgen Möller, Michael Riedel	18
8	The validity of self-rated psychotic symptoms in depressed inpatients 2011 ·European Psychiatry ·Florian Seemüller, Michael Riedel, Michael Obermeier, Rebecca Schennach-Wolff, Ilja Spellmann, Sebastian Meyer, Michael Bauer, Mazda Adli, Klaus‐Thomas Kronmüller, Marcus Ising, Peter Brieger, Gerd Laux, Wolfram Bender, Isabella Heuser, (unknown), Wolfgang Gäebel, H.‐J. Möller	14
9	Does Clinical Judgment of Baseline Severity and Changes in Psychopathology Depend on the Patient Population? 2010 ·Journal of Clinical Psychopharmacology ·Rebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, Markus Jäger, Max Schmauß, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz Schmidt, Wolfgang Gäebel, Joachim Klosterkötter, Isabella Heuser, Wolfgang Maier, Matthias Lemke, Eckart Rüther, Stefan Klingberg, Markus Gastpar, Rolf R. Engel, Hans‐Jürgen Möller, Michael Riedel	26
10	Response and remission criteria in major depression – A validation of current practice 2010 ·Journal of Psychiatric Research ·Michael Riedel, Hans‐Jürgen Möller, Michael Obermeier, Rebecca Schennach-Wolff, Michael Bauer, Mazda Adli, Klaus Kronmüller, Thomas Nickel, Peter Brieger, Gerd Laux, Wolfram Bender, Isabella Heuser, Joachim Zeiler, Wolfgang Gäebel, Florian Seemüller	223
11	The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia 2010 ·Quality of Life Research ·Michael Riedel, Ilja Spellmann, Rebecca Schennach-Wolff, Michael Obermeier, Richard Musil	7
12	The association of infectious agents and schizophrenia 2010 ·The World Journal of Biological Psychiatry ·Daniela Krause, (unknown), Elif Weidinger, Jenny Wagner, (unknown), Michael Obermeier, Michael Riedel, Norbert Müller	54
13	Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders 2010 ·European Psychiatry ·Rebecca Schennach-Wolff, Florian Seemüller, Michael Obermeier, Thomas Messer, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz Schmidt, Wolfgang Gäebel, Joachim Klosterkötter, Isabella Heuser, Wolfgang Maier, Matthias Lemke, E. Rüther, Gerhard Buchkremer, Markus Gastpar, Markus Jäger, H.‐J. Möller, Michael Riedel	13
14	The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: Assessing courses, types and time stability of diagnostic classification 2010 ·European Psychiatry ·H.‐J. Möller, Markus Jäger, Michael Riedel, Michael Obermeier, (unknown), Ronald Bottlender	35
15	Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone 2010 ·Human Psychopharmacology Clinical and Experimental ·Michael Riedel, Rebecca Schennach-Wolff, Richard Musil, Sandra Dehning, Anja Cerovecki, (unknown), (unknown), Florian Seemüller, Michael Obermeier, Rolf R. Engel, Norbert Müller, H.‐J. Möller, Ilja Spellmann	40
16	A Critical Analysis and Discussion of the Appropriateness of the Schizophrenia Consensus Remission Criteria in Clinical Pharmaceutical Trials 2010 ·Pharmacopsychiatry ·Rebecca Schennach-Wolff, H.-J. Möller, Markus Jäger, Florian Seemüller, Michael Obermeier, Thomas Messer, Gerd Laux, Herbert Pfeiffer, Д. Набер, Lutz Schmidt, Wolfgang Gäebel, Joachim Klosterkötter, Isabella Heuser, W. Maier, (unknown), E. Rüther, Stefan Klingberg, Markus Gastpar, Michael Riedel	2
17	Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? 2010 ·The Journal of Clinical Psychiatry ·Florian Seemüller, Hans‐Jürgen Möller, Michael Obermeier, Mazda Adli, Michael Bauer, Klaus Kronmüller, (unknown), Peter Brieger, Gerd Laux, Wolfram Bender, Isabella Heuser, Joachim Zeiler, Wolfgang Gäebel, Rebecca Schennach-Wolff, Verena Henkel, Michael Riedel	17
18	Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients 2010 ·Schizophrenia Research ·Markus Jäger, Michael Riedel, Michael Obermeier, Rebecca Schennach-Wolff, Florian Seemüller, Thomas Messer, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz Schmidt, Wolfgang Gäebel, Joachim Klosterkötter, Isabella Heuser, (unknown), Matthias Lemke, E. Rüther, Stefan Klingberg, Markus Gastpar, Ronald Bottlender, H.‐J. Möller	13
19	Are atypical depression and bipolar depression the same 2009 ·Bipolar Disorders ·Florian Seemüller, Sandra Dittmann, Heinz Grunze, Michael Obermeier, Michael Riedel, Emanuel Severus	1
20	Outcome of suicidal patients with schizophrenia: results from a naturalistic study 2009 ·Acta Psychiatrica Scandinavica ·Rebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, Michael Obermeier, Max Schmauß, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz Schmidt, Wolfgang Gäebel, Joachim Klosterkötter, Isabella Heuser, Wolfgang Maier, Matthias Lemke, E. Rüther, Stefan Klingberg, Markus Gastpar, H.‐J. Möller, Michael Riedel	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact